HEALEY ALS Platform Trial - Regimen I NUZ-001
What You Need to Know Before You Apply
What is the purpose of this trial?
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Regimen I will evaluate the safety and efficacy of a single study drug, NUZ-001, in participants with ALS.
Who Is on the Research Team?
Merit Cudkowicz, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
Inclusion Criteria
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
NUZ-001
Placebo Comparator: Matching Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Merit E. Cudkowicz, MD
Lead Sponsor
Neurizon Therapeutics Limited
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.